At least 50 patients go for CAR-T treatment to China, which has more than 200 outfits working in this area, say industry insiders. In comparison, India has three players, and only one of themImmunoACT has a CAR-T product available commercially.
But things could change.
Rahul Purwar, founder and chairman of ImmunoACT, says not many would have gone to China for treatment since the IIT Bombay spinoff, backed by Hyderabad-based Laurus Labs, started commercially offering CAR-T therapy (NexCAR19) in India last November.
"We are offering the treatment at $50,000 and their cost is around $200,000. So, India obviously has a major edge here," he says.
In the US, this costs $800,000$900,000 per patient, including pre and post-infusion care.
The immune system is the body's natural defence against infections and old or abnormal cells, including those that make up cancer. In CAR-T treatment, chimeric antigen receptor T cells (CAR-T) are genetically engineered to produce an artificial T cell receptor for use in immunotherapy.
Traditionally, CAR-T is delivered through the autologous route, which involves extracting the patient's blood, genetically re-engineering the cells, and infusing it back into the patient. The process takes three weeks or sovein to vein.
ImmunoACT's CAR-T product was approved by the Indian drug regulator last October for B-cell malignancies.
"If any country can bring the cost of this therapy down, it is India, as we have talented manpower," says Esha Kaul, Director, HaematoOncology, Bone Marrow Transplant, Max Super Speciality Hospital, Vaishali, on the outskirts of Delhi.
Purwar says around 2,500 patients are in the queue for receiving CAR-T treatment at ImmunoACT, which is increasing its capacity. In 2024-25, it will be able to process 300-500 patients, and by March 2025 it would have a capacity to process 2,000 patients a year.
Next frontier
This story is from the March 30, 2024 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the March 30, 2024 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Kansai Nerolac needs fresh coat to improve margins
Kansai Nerolac Paints has seen its market capitalisation (mcap) erode by over 5 per cent since May 3 after posting a subpar performance in the fourth quarter of 2023-24.
Cipla Promoters Offload 2.53% Stake For 2,637 Cr
Proceeds to be used for creating liquidity’ for philanthropy
US Protests: Why Are Faculty Voices Muted?
The silence of faculty underscores a shift where the pursuit of academic values takes a back seat to preserving financial interests
India's weight in MSCI equity index hits another high
India's weight in MSCI's Global Standard index, which tracks emerging market stocks, has risen to another record high, boosting prospects of more inflows into its equity markets.
Foreign investors most short on India stocks since 2012
Foreign investors are the most pessimistic in over a decade on Indian stocks amid speculation over Prime Minister Narendra Modi's party winning fewer seats in the ongoing national elections than previously estimated.
Raft of exemptions for government companies covers Sebi, MCA, CCI
Regulatory exemptions for government companies have been granted by multiple authorities. The Securities and Exchange Board of India (Sebi) has provided a raft of exemptions to listed public sector entities.
LIC gets until 2027 for 10% public shareholding
L ife Insurance Corporation (LIC) of India has been granted a three-year extension by the Securities and Exchange Board of India (Sebi) to achieve a 10 per cent public shareholding, the state-owned firm announced to the exchanges on Wednesday.
Leaning in: Isha Ambani beyond Reliance Retail
Ambani means business. Not only when she is doing business she .leads Reliance Retail-but also when she is not. The latter was unmistakable on Wednesday, during her eight-minute 49second video address on the occasion of Information and Communications Technology (ICT) Day India 2024\".
A MATTER OF ACCESS
What is on the cards for the India-Asean FTA review
Diplomacy from the outside in
This is a compelling and lucidly written memoir of a distinguished academic who established himself as a diplomat and special envoy, turfusually reserved for career diplomats. SD Muni was appointed by Prime Minister Inder Kumar Gujral as India's ambassador to Laos in 1997.
